The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2019

Filed:

Sep. 10, 2018
Applicant:

Immatics Biotechnologies Gmbh, Tübingen, DE;

Inventors:

Juliane Stickel, Tübingen, DE;

Daniel Johannes Kowalewski, Tübingen, DE;

Hans-Georg Rammensee, Unterjesingen, DE;

Stefan Stevanovic, Tübingen, DE;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 7/06 (2006.01); G01N 33/574 (2006.01); C12Q 1/6886 (2018.01); C12N 5/0783 (2010.01); C40B 30/02 (2006.01); C07K 14/74 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61K 39/0011 (2013.01); C07K 14/4748 (2013.01); C07K 14/70539 (2013.01); C12N 5/0638 (2013.01); C12Q 1/6886 (2013.01); C40B 30/02 (2013.01); G01N 33/574 (2013.01); A61K 39/00 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/585 (2013.01); C12N 2501/998 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/70539 (2013.01);
Abstract

The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to several novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.


Find Patent Forward Citations

Stickel, Juliane. (2019). Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll) (U.S. Patent No. 10167317). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10167317

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…